(Q44596535)

4 December 2017

title

Temozolomide in relapsed pediatric brain tumors: 14 cases from a single center (English)

1 reference

4 December 2017

0 references

1 reference

4

Bilgehan Yalçin

1 reference

4 December 2017

1

Canan Akyüz

1 reference

4 December 2017

3

Ali Varan

1 reference

4 December 2017

5

Tezer Kutluk

1 reference

4 December 2017

Münevver Büyükpamukçu

series ordinal

6

object named as

Münevver Büyükpamukçu

1 reference

4 December 2017

Haci Ahmet Demir

2

1 reference

4 December 2017

publication date

25 August 2011

1 reference

4 December 2017

published in

Child's Nervous System

1 reference

4 December 2017

volume

28

1 reference

4 December 2017

issue

1

1 reference

4 December 2017

page(s)

111-115

1 reference

https://scigraph.springernature.com/pub.10.1007/s00381-011-1561-3

4 December 2017

exact match

0 references

cites work

Temozolomide and radiation for aggressive pediatric central nervous system malignancies

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1561-3

Efficacy of temozolomide for recurrent embryonal brain tumors in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1561-3

Phase II trial of temozolomide in children with recurrent high-grade glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1561-3

Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1561-3

Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1561-3

Medulloblastoma in children: a 32-year experience from a single institution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1561-3

Phase I study of temozolomide combined with oral etoposide in children with recurrent or progressive medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1561-3

Astrocytic tumors in children: treatment results from a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1561-3

Role of temozolomide in pediatric brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1561-3

Temozolomide in pediatric low-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1561-3

Temozolomide in paediatric high-grade glioma: a key for combination therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1561-3

Temozolomide in resistant or relapsed pediatric solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1561-3

Temozolomide in children with progressive low-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1561-3

Phase I study of temozolomide in paediatric patients with advanced cancer. United Kingdom Children's Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1561-3

Phase I study of temozolomide in children and adolescents with recurrent solid tumors: a report from the Children's Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1561-3

Temozolomide and oral VP-16 for children and young adults with recurrent or treatment-induced malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1561-3

Phase I study of topotecan in combination with temozolomide (TOTEM) in relapsed or refractory paediatric solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1561-3

Reporting results of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1561-3

Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: results of a multiinstitutional study (SJHG-98).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1561-3

Childhood atypical teratoid rhabdoid tumor of the central nervous system: a meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1561-3

Safety and pharmacokinetics of temozolomide using a dose-escalation, metronomic schedule in recurrent paediatric brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1561-3

Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1561-3

Concurrent radiotherapy with temozolomide followed by adjuvant temozolomide and cis-retinoic acid in children with diffuse intrinsic pontine glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1561-3

Feasibility study of 21-day-on/7-day-off temozolomide in children with brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1561-3

Bone marrow transplantation for severe aplastic anemia secondary to temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1561-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1561-3

Acute lymphoblastic leukemia after temozolomide treatment for anaplastic astrocytoma in a child with a germline TP53 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00381-011-1561-3

A case of relapsed medulloblastoma treated with intensity-modulated radiotherapy and temozolomide.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21866330

12 December 2020

inferred from PubMed ID database lookup

Temozolomide and treatment of malignant glioma.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21866330

12 December 2020

inferred from PubMed ID database lookup

Concomitant radiotherapy and metronomic temozolomide in pediatric high-risk brain tumors.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21866330

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S00381-011-1561-3

1 reference

release_2dylcfzngbhqlk46762p3324cq

4 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2dylcfzngbhqlk46762p3324cq

24 November 2022

mapped directly with Wikidata item

1 reference